To improve diabetes management in the Lazio region of Italy, Quo-Lab® glycated hemoglobin (HbA1c) analyzers are being installed in all hospitals. This new initiative is part of a comprehensive campaign to provide clinicians and patients with better access to HbA1c testing, aiding in the management and treatment of diabetes.
The video, originally broadcast on Italian national television, shows the Quo-Lab® being used in daily routines and specialist diabetes clinics. The Quo-Lab® analyzer is a dedicated HbA1c system designed to deliver quick and cost-effective results at the point of care, allowing physicians to engage more closely with their patients.